Genelux (GNLX) Preferred Shares (2022)

Genelux's (GNLX) quarterly Preferred Shares came in at $22000.0 in Q4 2022.

Genelux (GNLX) Preferred Shares (2022) Analysis & Trends

Genelux's Preferred Shares history runs 1 years deep, the most recent figure standing at $22000.0 for Q4 2022.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $22000.0 in Q4 2022; TTM through Dec 2022 was $22000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $22000.0, changed N/A from the prior year.
Preferred Shares held at $22000.0 in Q4 2022 per GNLX's latest filing.
Across five years, Preferred Shares topped out at $22000.0 in Q4 2022 and bottomed at $22000.0 in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Genelux	129.36 Mn	129.36 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	22,000.00